Pharmacokinetic disposition and protein binding of furosemide in newborn infants. 1978

J V Aranda, and J Perez, and D S Sitar, and J Collinage, and A Portuguez-Malavasi, and B Duffy, and C Dupont

Using a one-compartment model, the pharmacokinetic disposition of furosemide was studied in eight premature and term neonates with fluid overload. Following a single intravenous injection of furosemide (1 to 1.5 mg/kg), multiple blood samples were obtained from a heelstick or an arterial catheter and analyzed for furosemide by gas liquid chromatography. The mean (+/- SE) apparent volume of distribution was 829.2 +/- 118.9 ml/kg; t1/2 was 7.7 +/- 1.0 hour; elimination rate constant was 0.102 +/- 0.013/hour and plasma clearance was 81.61 +/- 14.98 ml/kg/hour. Compared to the disposition of furosemide in normal adults. AVd is almost fourfold greater in the neonate with an eightfold prolongation in plasma t1/2, an eightfold decrease in Ke1, and a twofold decrease in plasma clearance. Neither gestational and postnatal age nor birth weight correlated with the pharmacokinetic variables. No significant change in reserve bilirubin-binding capacity after an intravenous dose of furosemide was noted. Slow elimination of furosemide may partly explain the prolonged diuretic and saluretic effect of furosemide in the neonate.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001663 Bilirubin A bile pigment that is a degradation product of HEME. Bilirubin IX alpha,Bilirubin, (15E)-Isomer,Bilirubin, (4E)-Isomer,Bilirubin, (4E,15E)-Isomer,Bilirubin, Calcium Salt,Bilirubin, Disodium Salt,Bilirubin, Monosodium Salt,Calcium Bilirubinate,Hematoidin,delta-Bilirubin,Bilirubinate, Calcium,Calcium Salt Bilirubin,Disodium Salt Bilirubin,Monosodium Salt Bilirubin,Salt Bilirubin, Calcium,delta Bilirubin
D012709 Serum Albumin A major protein in the BLOOD. It is important in maintaining the colloidal osmotic pressure and transporting large organic molecules. Plasma Albumin,Albumin, Serum

Related Publications

J V Aranda, and J Perez, and D S Sitar, and J Collinage, and A Portuguez-Malavasi, and B Duffy, and C Dupont
January 1987, Developmental pharmacology and therapeutics,
J V Aranda, and J Perez, and D S Sitar, and J Collinage, and A Portuguez-Malavasi, and B Duffy, and C Dupont
September 1983, The Journal of pediatrics,
J V Aranda, and J Perez, and D S Sitar, and J Collinage, and A Portuguez-Malavasi, and B Duffy, and C Dupont
January 1985, Archives francaises de pediatrie,
J V Aranda, and J Perez, and D S Sitar, and J Collinage, and A Portuguez-Malavasi, and B Duffy, and C Dupont
October 1974, Research communications in chemical pathology and pharmacology,
J V Aranda, and J Perez, and D S Sitar, and J Collinage, and A Portuguez-Malavasi, and B Duffy, and C Dupont
August 1993, Biochemical pharmacology,
J V Aranda, and J Perez, and D S Sitar, and J Collinage, and A Portuguez-Malavasi, and B Duffy, and C Dupont
December 1984, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine,
J V Aranda, and J Perez, and D S Sitar, and J Collinage, and A Portuguez-Malavasi, and B Duffy, and C Dupont
April 1977, Archives of disease in childhood,
J V Aranda, and J Perez, and D S Sitar, and J Collinage, and A Portuguez-Malavasi, and B Duffy, and C Dupont
May 1984, Antimicrobial agents and chemotherapy,
J V Aranda, and J Perez, and D S Sitar, and J Collinage, and A Portuguez-Malavasi, and B Duffy, and C Dupont
January 1985, Clinical therapeutics,
J V Aranda, and J Perez, and D S Sitar, and J Collinage, and A Portuguez-Malavasi, and B Duffy, and C Dupont
January 1982, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!